vTv Therapeutics Inc
NASDAQ:VTVT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
vTv Therapeutics Inc
NASDAQ:VTVT
|
US |
|
B
|
BioCryst Pharmaceuticals Inc
F:BO1
|
US |
|
Byrna Technologies Inc
NASDAQ:BYRN
|
US |
|
C
|
Ctac NV
AEX:CTAC
|
NL |
|
T
|
TCS Group Holding PLC
MOEX:TCSG
|
CY |
|
Meituan
F:9MD
|
CN |
Wall St Price Targets
VTVT Price Targets Summary
vTv Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VTVT is 55.896 USD with a low forecast of 45.45 USD and a high forecast of 70.35 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VTVT's stock price target?
Price Target
55.896
USD
According to Wall Street analysts, the average 1-year price target for
VTVT is 55.896 USD with a low forecast of 45.45 USD and a high forecast of 70.35 USD.